Literature DB >> 25346871

Test-Retest Intervisit Variability of Functional and Structural Parameters in X-Linked Retinoschisis.

Brett G Jeffrey1, Catherine A Cukras1, Susan Vitale1, Amy Turriff1, Kristin Bowles2, Paul A Sieving1.   

Abstract

PURPOSE: To examine the variability of four outcome measures that could be used to address safety and efficacy in therapeutic trials with X-linked juvenile retinoschisis.
METHODS: Seven men with confirmed mutations in the RS1 gene were evaluated over four visits spanning 6 months. Assessments included visual acuity, full-field electroretinograms (ERG), microperimetric macular sensitivity, and retinal thickness measured by optical coherence tomography (OCT). Eyes were separated into Better or Worse Eye groups based on acuity at baseline. Repeatability coefficients were calculated for each parameter and jackknife resampling used to derive 95% confidence intervals (CIs).
RESULTS: The threshold for statistically significant change in visual acuity ranged from three to eight letters. For ERG a-wave, an amplitude reduction greater than 56% would be considered significant. For other parameters, variabilities were lower in the Worse Eye group, likely a result of floor effects due to collapse of the schisis pockets and/or retinal atrophy. The criteria for significant change (Better/Worse Eye) for three important parameters were: ERG b/a-wave ratio (0.44/0.23), point wise sensitivity (10.4/7.0 dB), and central retinal thickness (31%/18%).
CONCLUSIONS: The 95% CI range for visual acuity, ERG, retinal sensitivity, and central retinal thickness relative to baseline are described for this cohort of participants with X-linked juvenile retinoschisis (XLRS). TRANSLATIONAL RELEVANCE: A quantitative understanding of the variability of outcome measures is vital to establishing the safety and efficacy limits for therapeutic trials of XLRS patients.

Entities:  

Keywords:  MP1; OCT; XLRS; electroretinogram; retinoschisis

Year:  2014        PMID: 25346871      PMCID: PMC4187428          DOI: 10.1167/tvst.3.5.5

Source DB:  PubMed          Journal:  Transl Vis Sci Technol        ISSN: 2164-2591            Impact factor:   3.283


  59 in total

1.  Measuring geographic atrophy in advanced age-related macular degeneration.

Authors:  J S Sunness; N M Bressler; Y Tian; J Alexander; C A Applegate
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-07       Impact factor: 4.799

2.  Rod sensitivity, cone sensitivity, and photoreceptor layer thickness in retinal degenerative diseases.

Authors:  David G Birch; Yuquan Wen; Kelly Locke; Donald C Hood
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-09       Impact factor: 4.799

3.  An ENU-induced mutation in Rs1h causes disruption of retinal structure and function.

Authors:  Monica M Jablonski; Claudia Dalke; XiaoFei Wang; Lu Lu; Kenneth F Manly; Walter Pretsch; Jack Favor; Machelle T Pardue; Eugene M Rinchik; Robert W Williams; Daniel Goldowitz; Jochen Graw
Journal:  Mol Vis       Date:  2005-07-27       Impact factor: 2.367

4.  A proposed method of logarithmic transformation of optical coherence tomography data for use in clinical research.

Authors:  Frederick L Ferris; Kellee M Miller; Adam R Glassman; Roy W Beck
Journal:  Ophthalmology       Date:  2010-04-03       Impact factor: 12.079

5.  Macular function in macular degenerations: repeatability of microperimetry as a potential outcome measure for ABCA4-associated retinopathy trials.

Authors:  Artur V Cideciyan; Malgorzata Swider; Tomas S Aleman; Willam J Feuer; Sharon B Schwartz; Robert C Russell; Janet D Steinberg; Edwin M Stone; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-21       Impact factor: 4.799

6.  Visual acuity in 183 cases of X-chromosomal retinoschisis.

Authors:  H Forsius; U Krause; J Helve; V Vuopala; E Mustonen; B Vainio-Mattila; J Fellman; A W Eriksson
Journal:  Can J Ophthalmol       Date:  1973-07       Impact factor: 1.882

7.  Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

8.  Effect of aging on macular features of X-linked retinoschisis assessed with optical coherence tomography.

Authors:  Marcel N Menke; Gilbert T Feke; Tatsuo Hirose
Journal:  Retina       Date:  2011-06       Impact factor: 4.256

9.  Fundus findings and longitudinal study of visual acuity loss in patients with X-linked retinoschisis.

Authors:  Marsha A Apushkin; Gerald A Fishman; Aruna S Rajagopalan
Journal:  Retina       Date:  2005 Jul-Aug       Impact factor: 4.256

10.  Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial.

Authors:  Albert M Maguire; Katherine A High; Alberto Auricchio; J Fraser Wright; Eric A Pierce; Francesco Testa; Federico Mingozzi; Jeannette L Bennicelli; Gui-shuang Ying; Settimio Rossi; Ann Fulton; Kathleen A Marshall; Sandro Banfi; Daniel C Chung; Jessica I W Morgan; Bernd Hauck; Olga Zelenaia; Xiaosong Zhu; Leslie Raffini; Frauke Coppieters; Elfride De Baere; Kenneth S Shindler; Nicholas J Volpe; Enrico M Surace; Carmela Acerra; Arkady Lyubarsky; T Michael Redmond; Edwin Stone; Junwei Sun; Jennifer Wellman McDonnell; Bart P Leroy; Francesca Simonelli; Jean Bennett
Journal:  Lancet       Date:  2009-10-23       Impact factor: 79.321

View more
  22 in total

1.  Reliability of kinetic visual field testing in children with mutation-proven retinal dystrophies: Implications for therapeutic clinical trials.

Authors:  Vaidehi S Dedania; Jerry Y Liu; Dana Schlegel; Chris A Andrews; Kari Branham; Naheed W Khan; David C Musch; John R Heckenlively; K Thiran Jayasundera
Journal:  Ophthalmic Genet       Date:  2017-07-13       Impact factor: 1.803

2.  Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I/IIa Trial by Intravitreal Delivery.

Authors:  Catherine Cukras; Henry E Wiley; Brett G Jeffrey; H Nida Sen; Amy Turriff; Yong Zeng; Camasamudram Vijayasarathy; Dario Marangoni; Lucia Ziccardi; Sten Kjellstrom; Tae Kwon Park; Suja Hiriyanna; J Fraser Wright; Peter Colosi; Zhijian Wu; Ronald A Bush; Lisa L Wei; Paul A Sieving
Journal:  Mol Ther       Date:  2018-07-07       Impact factor: 11.454

Review 3.  Juvenile Macular Degenerations.

Authors:  Pablo Altschwager; Lucia Ambrosio; Emily A Swanson; Anne Moskowitz; Anne B Fulton
Journal:  Semin Pediatr Neurol       Date:  2017-05-23       Impact factor: 1.636

4.  Patient-reported outcome measures in inherited retinal degeneration gene therapy trials.

Authors:  Gabrielle D Lacy; Maria Fernanda Abalem; David C Musch; Kanishka T Jayasundera
Journal:  Ophthalmic Genet       Date:  2020-02-26       Impact factor: 1.803

5.  Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.

Authors:  David G Birch; Paul S Bernstein; Alessandro Iannacone; Mark E Pennesi; Byron L Lam; John Heckenlively; Karl Csaky; Mary Elizabeth Hartnett; Kevin L Winthrop; Thiran Jayasundera; Dianna K Hughbanks-Wheaton; Judith Warner; Paul Yang; Gary Edd Fish; Michael P Teske; Neal L Sklaver; Laura Erker; Elvira Chegarnov; Travis Smith; Aimee Wahle; Paul C VanVeldhuisen; Jennifer McCormack; Robert Lindblad; Steven Bramer; Stephen Rose; Patricia Zilliox; Peter J Francis; Richard G Weleber
Journal:  JAMA Ophthalmol       Date:  2018-08-01       Impact factor: 7.389

6.  Detailed Morphological Changes of Foveoschisis in Patient with X-Linked Retinoschisis Detected by SD-OCT and Adaptive Optics Fundus Camera.

Authors:  Keiichiro Akeo; Shuhei Kameya; Kiyoko Gocho; Daiki Kubota; Kunihiko Yamaki; Hiroshi Takahashi
Journal:  Case Rep Ophthalmol Med       Date:  2015-08-18

Review 7.  Clinical Perspectives and Trends: Microperimetry as a Trial Endpoint in Retinal Disease.

Authors:  Yesa Yang; Hannah Dunbar
Journal:  Ophthalmologica       Date:  2021-02-10       Impact factor: 3.250

8.  Reproducibility of Full-field Electroretinogram Measurements in Birdshot Chorioretinopathy Patients: An Intra- and Inter-visit Analysis.

Authors:  Jared E Knickelbein; Brett G Jeffrey; Maggie M Wei; Shuk Kei Cheng; Natasha Kesav; Susan Vitale; H Nida Sen
Journal:  Ocul Immunol Inflamm       Date:  2020-01-04       Impact factor: 3.728

9.  Calculation of test-retest variability in phase I/IIa clinical trials for Inherited Retinal Degenerations.

Authors:  Jacob Jeries Abou-Hanna; Chris A Andrews; Naheed W Khan; David C Musch; K Thiran Jayasundera
Journal:  Ophthalmic Genet       Date:  2021-03-17       Impact factor: 1.274

10.  Intersession Test-Retest Variability of Microperimetry in Type 2 Macular Telangiectasia.

Authors:  Evan N Wong; Jehan D A De Soyza; David A Mackey; Ian J Constable; Fred K Chen
Journal:  Transl Vis Sci Technol       Date:  2017-12-12       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.